PRP Injection Therapy for Sports & Orthopaedic Injuries

Platelet-Rich Plasma (PRP) injection therapy uses your own concentrated platelets and growth factors to stimulate natural healing in tendons, ligaments, cartilage, and muscle injuries. Senior orthopaedic surgeons at SSOC administer PRP to treat sports injuries and degenerative joint conditions as a non-surgical alternative.

Platelet-Rich Plasma (PRP) therapy at Singapore Sports & Orthopaedic Clinic is a regenerative treatment that uses the patient's own blood to promote tissue healing, reduce inflammation, and restore function in damaged musculoskeletal structures. The procedure is performed by senior orthopaedic surgeons who specialise in sports injuries and joint conditions, making SSOC one of Singapore's most clinically credentialed centres for orthopaedic PRP therapy. The process begins with a small blood draw, typically 15–30 ml, which is then centrifuged to separate and concentrate the platelet-rich fraction. This PRP solution contains a high density of growth factors — including Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-β), Vascular Endothelial Growth Factor (VEGF), and Insulin-Like Growth Factor (IGF) — that collectively drive tissue repair, collagen synthesis, and angiogenesis at the injury site. The concentrated PRP is then precisely injected into the affected area under clinical guidance. At SSOC, PRP is used to treat a broad spectrum of orthopaedic conditions, including patellar tendinopathy (jumper's knee), Achilles tendon injuries, rotator cuff tears and tendinosis, lateral epicondylitis (tennis elbow), medial epicondylitis (golfer's elbow), knee osteoarthritis and cartilage wear, hamstring and quadriceps muscle tears, ligament sprains of the knee and ankle, and plantar fasciitis. The clinic's team of senior consultants evaluates each patient individually to determine whether PRP is appropriate, either as a standalone treatment or in combination with physiotherapy, shockwave therapy, or surgical repair. Most PRP sessions take approximately 20–30 minutes from blood draw to injection. Patients may experience mild localised swelling and discomfort in the days immediately following the procedure, as this inflammatory response is part of the healing cascade triggered by PRP. Meaningful improvement is typically observed over a 4–8 week window, with peak results often seen at 3–6 months. Some patients benefit from a course of two to three PRP injections spaced several weeks apart, particularly for chronic or degenerative conditions. The primary advantage of PRP therapy is its autologous nature — because the treatment uses the patient's own blood, there is negligible risk of allergic reaction or rejection. This safety profile, combined with the growing body of clinical evidence supporting PRP for musculoskeletal conditions, makes it a compelling option for patients seeking to avoid or delay surgery, or to accelerate recovery following injury. Post-injection, patients are typically advised to rest the treated area for 24–48 hours, avoid anti-inflammatory medications for several weeks, and engage in a guided rehabilitation programme to maximise outcomes.